Finance

Beta
Lists
HRTX:NASDAQ
Heron Therapeutics Inc
၀.၄၅ US$
+၄.၆၅%
(+၀.၀၂၀) 1D
၀.၄၄ US$
-၁.၂၃% (-၀.၀၀၅၅)
Pre-market
Closed: ဇူ ၈, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HRTX...
Open
၀.၄၂ US$
High
၀.၄၅ US$
Low
၀.၄၂ US$
Mkt. cap
၈.၃၅ ကုဋေ
Avg. vol.
၄.၂၂ သန်း
Volume
၅၆၇.၀၀
52-wk high
၂.၂၈ US$
52-wk low
၀.၃၈ US$
EPS
-၀.၁၈ US$
Beta
၁.၆၅
Shares outstanding
၁၈.၉၃ ကုဋေ
No. of employees
၁၂၈
Open
၀.၄၂ US$
High
၀.၄၅ US$
Low
၀.၄၂ US$
Mkt. cap
၈.၃၅ ကုဋေ
Avg. vol.
၄.၂၂ သန်း
Volume
၅၆၇.၀၀
52-wk high
၂.၂၈ US$
52-wk low
၀.၃၈ US$
EPS
-၀.၁၈ US$
Beta
၁.၆၅
Shares outstanding
၁၈.၉၃ ကုဋေ
No. of employees
၁၂၈
News stories
From sources across the web
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၂၆ မိနစ်
Trident Digital Tech Holdings (Nasdaq: TDTH) Takes Strategic Equity Stake in U.S Based Digital Innovations Group to Commercialize the AI-Powered IRMA Engine Across Asia-Pacific and Africa
Nasdaq
Nasdaq
·
ပြီးခဲ့သည့် ၂၉ မိနစ်
LifeMD Rings the Closing Bell
24/7 Wall St.
24/7 Wall St.
·
ပြီးခဲ့သည့် ၁၂ မိနစ်
The Nasdaq 100’s 5 Highest-Yielding Stocks Are Hot Summer Picks
The Motley Fool
The Motley Fool
·
ပြီးခဲ့သည့် ၈ မိနစ်
The Market Had a Fantastic Second Quarter. But Here's the Warning No One Is Talking About.
About Heron Therapeutics Inc
CEO-
Employees၁၂၈
Founded၁၉၈၃
Headquartersဆန်ဒီရေဂို, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteherontx.com
Analyst ratings
Based on 2 analysts giving stock ratings to HRTX in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for HRTX in the last 3 months.
Highest
Current ၀.၄၅ US$
၂.၀၀ US$ (+၃၄၈.၉၃%)
Average
၂.၀၀ US$ (+၃၄၈.၉၃%)
Lowest
၂.၀၀ US$ (+၃၄၈.၉၃%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Maintained
၂.၀၀ US$
+၃၄၈.၉%
06/08/2026
Serge Belanger
Needham
Hold
Downgraded
-
-
06/02/2026
Carl Byrnes
Northland Securities
Buy
Reiterated
၄.၀၀ US$
+၇၉၇.၉%
11/05/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၃.၇၂ ကုဋေ
၃.၈၂ ကုဋေ
၄.၀၆ ကုဋေ
၃.၄၇ ကုဋေ
Cost of goods sold
၁.၂၈ ကုဋေ
၁.၅၄ ကုဋေ
၁.၄၉ ကုဋေ
၁.၃၀ ကုဋေ
Cost of revenue
၁.၂၈ ကုဋေ
၁.၅၄ ကုဋေ
၁.၄၉ ကုဋေ
၁.၃၀ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂.၆၀ ကုဋေ
၂.၆၉ ကုဋေ
၂.၅၇ ကုဋေ
၂.၆၅ ကုဋေ
Operating expense
၂.၆၀ ကုဋေ
၂.၆၉ ကုဋေ
၂.၅၇ ကုဋေ
၂.၆၅ ကုဋေ
Total operating expenses
၃.၈၈ ကုဋေ
၄.၂၃ ကုဋေ
၄.၀၆ ကုဋေ
၃.၉၅ ကုဋေ
Operating income
-၁.၆၄ သန်း
-၄.၀၉ သန်း
၃.၈၀ သောင်း
-၄.၇၆ သန်း
Other non operating income
၇.၅၆ သိန်း
၈.၃၇ သိန်း
-၈.၂၁ သိန်း
-၁.၄၆ သိန်း
EBT including unusual items
-၂.၃၈ သန်း
-၁.၇၅ ကုဋေ
-၂.၉၅ သန်း
-၈.၁၁ သန်း
EBT excluding unusual items
-၂.၃၈ သန်း
-၆.၁၆ သန်း
-၂.၅၄ သန်း
-၈.၁၁ သန်း
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၂.၃၈ သန်း
-၁.၇၅ ကုဋေ
-၂.၉၅ သန်း
-၈.၁၁ သန်း
Net profit margin
-၆.၄၀%
-၄၅.၇၈%
-၇.၂၈%
-၂၃.၃၇%
Earnings per share
-၀.၀၂
-၀.၀၄
-၀.၀၂
-၀.၀၄
Interest and investment income
-
-
၁.၉၅ သန်း
-
Interest expense
-၁.၅၀ သန်း
-၂.၉၀ သန်း
-၃.၇၀ သန်း
-၃.၂၀ သန်း
Net interest expenses
-၁.၅၀ သန်း
-၂.၉၀ သန်း
-၁.၇၆ သန်း
-၃.၂၀ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၀၃ သန်း
-၃.၄၈ သန်း
၅.၇၅ သိန်း
-၄.၂၄ သန်း
Gain or loss from assets sale
၁.၂၉ သိန်း
-၉.၅၀ သောင်း
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer